ExodusPoint Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729K | Buy |
56,054
+1,140
| +2% | +$14.8K | 0.01% | 988 |
|
|
2025
Q1 | $582K | Buy |
+54,914
| New | +$582K | 0.01% | 1022 |
|
|
2024
Q1 | – | Sell |
-9,499
| Closed | -$300K | – | 1348 |
|
|
2023
Q4 | $300K | Sell |
9,499
-13,538
| -59% | -$428K | ﹤0.01% | 1112 |
|
|
2023
Q3 | $589K | Buy |
23,037
+1,861
| +9% | +$47.6K | 0.01% | 1137 |
|
|
2023
Q2 | $607K | Sell |
21,176
-8,988
| -30% | -$258K | ﹤0.01% | 1198 |
|
|
2023
Q1 | $723K | Buy |
30,164
+348
| +1% | +$8.34K | 0.01% | 1150 |
|
|
2022
Q4 | $506K | Sell |
29,816
-17,736
| -37% | -$301K | 0.01% | 1140 |
|
|
2022
Q3 | $705K | Buy |
+47,552
| New | +$705K | 0.01% | 1213 |
|
|
2021
Q4 | – | Sell |
-21,937
| Closed | -$1.05M | – | 2098 |
|
|
2021
Q3 | $1.05M | Buy |
+21,937
| New | +$1.05M | 0.01% | 955 |
|
|
2021
Q1 | – | Sell |
-23,302
| Closed | -$1.01M | – | 2043 |
|
|
2020
Q4 | $1.01M | Sell |
23,302
-13,753
| -37% | -$597K | 0.01% | 799 |
|
|
2020
Q3 | $1.59M | Buy |
+37,055
| New | +$1.59M | 0.03% | 436 |
|
|
2020
Q1 | – | Sell |
-11,135
| Closed | -$121K | – | 1027 |
|
|
2019
Q4 | $121K | Buy |
+11,135
| New | +$121K | ﹤0.01% | 1356 |
|